What does PA stand for?

Pancreatic Adenocarcinoma

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Paisley (postcode, United Kingdom) Pakistan Army Pale Ale Palermo, Sicilia (Italian province) Palestinian Authority Pali (linguistics) Palo Alto (California) Pamela Anderson Pan Am (airline) Panama		Paniagua y Asociados (Guatemala, consulting agency) Pantothenic Acid Paper Advance Para (Brazil) Pará (Brazilian state) Paraguay Paralegal Paralyzed Age (band) Paramedic's Assistant Parapsychological Association, Inc (Petaluma, California)

Samples in periodicals archive:

For the case control study, the researchers enrolled 1,838 participants - 973 patients with pancreatic adenocarcinoma treated at M.

Common diabetic therapy reduces pancreatic cancer risk

Association of P53 gene mutation with short survival in pancreatic adenocarcinoma, Jpn J Cancer Res.

New advance in pancreatic cancer

Pancreatic islet cell tumours are very rare neuroendocrine tumours which are less aggressive and slower growing than the more common pancreatic adenocarcinomas.

11th World Congress on Gastrointestinal Cancer of the European ...

15) Malignant biliary obstruction is usually secondary to pancreatic adenocarcinoma or is due to cholangiocarcinoma of the common bile, or common hepatic duct (including the bifurcation, collectively called hilar), or the intrahepatic bile ducts (peripheral).

CT for upper abdominal pathology--is imaging of the pelvis necessary?

1) For pancreatic adenocarcinoma, CA 19-9 is reported to have a sensitivity of 70 to 90%, specificity of about 90%, a positive predictive value of 69%, and a negative predictive value of 90%.

CA 19-9: not a magic marker for pancreatic cancer

Bilateral sudden hearing loss and metastatic pancreatic adenocarcinoma.

Metastasis of colonic adenocarcinoma to the external ear canal: an ...

Asuragen has used this funding to develop and commercialize products ranging from nucleic acid isolation, detection and profiling technologies, to the first commercially available miRNA-based diagnostic test for pancreatic adenocarcinoma.

Asuragen Awarded More Than $3.8 Million in New NIH Small Business ...

Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.

Current issues in the treatment of pancreatic cancer